The fact
The biopharmaceutical company targets a possible dividend starting in 2029.
Shareholders react with volatility in the markets.
Click the link to read an article on the topic:
The biopharmaceutical company targets a possible dividend starting in 2029.
Shareholders react with volatility in the markets.